4.5 Review

Pancreatic β-cell identity, glucose sensing and the control of insulin secretion

Journal

BIOCHEMICAL JOURNAL
Volume 466, Issue -, Pages 203-218

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BJ20141384

Keywords

insulin; diabetes; glucose; beta cell; islet; pancreas; secretion; imaging; electrophysiology; recombinant probe

Funding

  1. Wellcome Trust [WT098424AIA]
  2. MRC Programme [MR/J0003042/1]
  3. Diabetes UK [11/0004210, BDA 12/0004431]
  4. Royal Society Wolfson Research Merit Awards Diabetes Research and Wellness Foundation Non-clinical Fellowship [SCA/01/F/12]
  5. Innovative Medicines Initiative Joint Undertaking [155005]
  6. European Union's Seventh Framework Programme [FP7/2007-2013]
  7. EFPIA companies'
  8. MRC [MR/K001981/1] Funding Source: UKRI
  9. Medical Research Council [MR/K001981/1] Funding Source: researchfish

Ask authors/readers for more resources

Insulin release from pancreatic beta-cells is required to maintain normal glucose homoeostasis in man and many other animals. Defective insulin secretion underlies all forms of diabetes mellitus, a disease currently reaching epidemic proportions worldwide. Although the destruction of beta-cells is responsible for Type 1 diabetes (T1D), both lowered beta-cell mass and loss of secretory function are implicated in Type 2 diabetes (T2D). Emerging results suggest that a functional deficiency, involving de-differentiation of the mature beta-cell towards a more progenitor-like state, may be an important driver for impaired secretion in T2D. Conversely, at least in rodents, reprogramming of islet non-alpha to beta-cells appears to occur spontaneously in models of T1D, and may occur in man. In the present paper, we summarize the biochemical properties which define the 'identity' of the mature beta-cell as a glucose sensor par excellence. In particular, we discuss the importance of suppressing a group of 11 'disallowed' housekeeping genes, including Ldha and the monocarboxylate transporter Mct1 (Slc16a1), for normal nutrient sensing. We then survey the changes in the expression and/or activity of beta-cell-enriched transcription factors, including FOXO1, PDX1, NKX6.1, MAFA and RFX6, as well as non-coding RNAs, which may contribute to beta-cell de-differentiation and functional impairment in T2D. The relevance of these observations for the development of new approaches to treat T1D and T2D is considered.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available